Next Article in Journal
Barriers to Accessing Treatment Services: Child Victims of Youths with Problematic Sexual Behavior
Previous Article in Journal
Digital Quantification of Occlusal Contacts: A Methodological Study
Study Protocol

Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial

1
Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
2
Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Korea
3
Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea, Seoul 06591, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: U Rajendra Acharya
Int. J. Environ. Res. Public Health 2021, 18(10), 5300; https://doi.org/10.3390/ijerph18105300
Received: 9 March 2021 / Revised: 5 May 2021 / Accepted: 12 May 2021 / Published: 16 May 2021
(This article belongs to the Section Digital Health)
Controlling type 2 diabetes (T2DM) requires a comprehensive approach including patient education, self-monitoring of blood glucose, individualized behavioral strategies, and frequent contact with healthcare professionals (HCPs). We aimed to compare the efficacy of a personalized lifestyle intervention based on a mobile phone application with regular care in participants with T2DM. This is an ongoing randomized controlled open-label parallel-group trial with a target accrual of 282 participants, of which 181 have been enrolled to date. Participants are randomly assigned to one of three groups: (1) regular care; (2) mobile diabetes management; or (3) mobile diabetes management with HCP feedback. The mobile application is enabled to integrate with both electronic medical records (EMR) and a web-based diabetes management system for HCPs. It can send customized messages based on participants’ responses to lifestyle questionnaires administered at the baseline. The intervention period is 26 weeks followed by observation for 26 weeks. We evaluate the intervention’s features in order to assess its clinical utility and efficacy and compare outcomes with regular care considering relevant clinical factors, such as age, baseline HbA1c, etc. We expect our study to provide new evidence in support of customized mobile application tools for the management of T2DM. View Full-Text
Keywords: type 2 diabetes mellitus; digital health; mHealth; self-monitoring type 2 diabetes mellitus; digital health; mHealth; self-monitoring
Show Figures

Figure 1

MDPI and ACS Style

Lee, E.-Y.; Yun, J.-S.; Cha, S.-A.; Lim, S.-Y.; Lee, J.-H.; Ahn, Y.-B.; Yoon, K.-H.; Ko, S.-H. Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2021, 18, 5300. https://doi.org/10.3390/ijerph18105300

AMA Style

Lee E-Y, Yun J-S, Cha S-A, Lim S-Y, Lee J-H, Ahn Y-B, Yoon K-H, Ko S-H. Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial. International Journal of Environmental Research and Public Health. 2021; 18(10):5300. https://doi.org/10.3390/ijerph18105300

Chicago/Turabian Style

Lee, Eun-Young; Yun, Jae-Seung; Cha, Seon-Ah; Lim, Sun-Young; Lee, Jin-Hee; Ahn, Yu-Bae; Yoon, Kun-Ho; Ko, Seung-Hyun. 2021. "Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial" Int. J. Environ. Res. Public Health 18, no. 10: 5300. https://doi.org/10.3390/ijerph18105300

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop